EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer

Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Takashi Yamane, Naoki Shiota, Hiroshi Ohnishi, Hisanori Machida, Nobuo Hatakeyama, Eiji Takeuchi, Tomoyuki Urata, Fumitaka Ogushi, Akihito Yokoyama

Advances in Lung Cancer · 2014

DOI: 10.4236/alc.2014.31002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Lung Cancer, 2014. Verfasst von Tetsuya Kubota und 11 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kubota, T., Okano, Y., Sakai, M., Yamane, T., Shiota, N., Ohnishi, H., Machida, H., Hatakeyama, N., Takeuchi, E., Urata, T., Ogushi, F., & Yokoyama, A. (2014). A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer. Advances in Lung Cancer. https://doi.org/10.4236/alc.2014.31002

Vancouver

Kubota T, Okano Y, Sakai M, Yamane T, Shiota N, Ohnishi H, et al. A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer. Advances in Lung Cancer. 2014. doi:10.4236/alc.2014.31002

BibTeX
@article{Kubota2014,
  author = {Kubota, Tetsuya and Okano, Yoshio and Sakai, Mizu and Yamane, Takashi and Shiota, Naoki and Ohnishi, Hiroshi and Machida, Hisanori and Hatakeyama, Nobuo and Takeuchi, Eiji and Urata, Tomoyuki and Ogushi, Fumitaka and Yokoyama, Akihito},
  title = {A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer},
  journal = {Advances in Lung Cancer},
  year = {2014},
  doi = {10.4236/alc.2014.31002}
}
Kostenlos starten →